anubhai
Back OfficeNippon India Pharma Fund (G)
Summary
| Fund Name | Nippon India Mutual Fund |
| Scheme Name | Nippon India Pharma Fund (G) |
| AMC | Nippon India Mutual Fund |
| Type | Open |
| Category | Equity - Pharma |
| Launch Date | 10-May-2004 |
| Fund Manager | Sailesh Raj Bhan |
| Net Assets(Rs. cr) | 9,044.23 |
NAV Graph
Latest Payouts
| Dividends | Bonus |
|---|
Performance
| 1 Week (%) | 1 Month (%) | 3 Month (%) | 6 Month (%) | 1 Year (%) | 3 Year (%) | 5 Year (%) | Since INC (%) | |
|---|---|---|---|---|---|---|---|---|
| Scheme Return | 2.44 | 2.20 | 10.18 | 16.89 | 7.33 | 18.50 | 12.87 | 20.01 |
| Category Avg | 2.72 | 3.65 | 14.00 | 22.57 | 12.77 | 21.24 | 14.75 | 17.59 |
| Category Best | 4.07 | 5.85 | 17.82 | 30.72 | 20.57 | 24.42 | 18.21 | 31.75 |
| Category Worst | 1.69 | 1.35 | 7.95 | 13.57 | 3.83 | 17.87 | 11.26 | 6.97 |
Asset Allocation
Holdings
| Company Name | % Hold |
|---|---|
| Sun Pharma.Inds. | 12.78 |
| Lupin | 7.45 |
| Dr Reddy's Labs | 6.68 |
| Cipla | 6.15 |
| Divi's Lab. | 5.46 |
| Apollo Hospitals | 5.27 |
| Mankind Pharma | 4.03 |
| Sai Life | 3.49 |
| Ajanta Pharma | 3.46 |
| Max Healthcare | 3.32 |
| Medplus Health | 3.18 |
| Vijaya Diagnost. | 2.80 |
| Thyrocare Tech. | 2.65 |
| Ipca Labs. | 2.57 |
| Glaxosmi. Pharma | 2.47 |
| Gland Pharma | 2.21 |
| Abbott India | 2.09 |
| Alkem Lab | 1.99 |
| Dr Lal Pathlabs | 1.85 |
| Narayana Hrudaya | 1.80 |
| Aurobindo Pharma | 1.75 |
| Syngene Intl. | 1.70 |
| Pfizer | 1.56 |
| Emcure Pharma | 1.52 |
| Fortis Health. | 1.42 |
| Suraksha Diagno. | 1.18 |
| Sanofi Consumer | 1.09 |
| Akums Drugs | 1.03 |
| Piramal Pharma | 1.02 |
| Anthem Bioscienc | 0.90 |
| Sanofi India | 0.87 |
| Biocon | 0.68 |
| Astrazeneca Phar | 0.57 |
| Indoco Remedies | 0.49 |
| Concord Biotech | 0.16 |
| TREPS | 2.30 |
| Net CA & Others | 0.05 |
| C C I | 0.01 |
